Phase-resetting efect of 8-OH-DPAT, a serotonin1A receptor agonist, on the circadian rhythm of firing rate in the rat suprachiasmatic nuclei in vitro

Shigenobu Shibata, Atsuko Tsuneyoshi, Toshiyuki Hamada, Keiko Tominaga, Shigenori Watanabe

研究成果: Article

102 引用 (Scopus)

抄録

The 5-HTergic neurons in the mesencephalic raphe nuclei provide a robust projection to the hypothalamic suprachiasmatic nucleus (SCN), the site of a putative neuronal circadian pacemaker. Although it has been suggested that 5-HT neurons may play a role in the circadian timing system, this role has not yet been specified. Prosser et al. (Brain Res., 534 (1990) 336-339) reported that 1 h treatments with quipazine induce robust phase shifts in vitro, and that this effect depends upon the circadian time of treatment. However, quipazine is a non-specific 5-HT agonist. Besides, it is reported that the 5-HT1A agonist, 8-hydroxy-2-(di-n-propylamino)tetraline hydrobromide (8-OH-DPAT) affected a circadian rhythm of hamster wheel-running activity. In the present study we investigated whether the 5-HT1A agonist 8-OH-DPAT can reset the phase of the SCN clock when it is isolated in vitro. The present results show that 1 h treatments with 8-OH-DPAT induce robust phase advances in vitro when it was administered during the subjective day. This result suggests that 5HT1A receptor functioning may play a role in modulating the phase of SCN clock, especially during the subjective day.

元の言語English
ページ(範囲)353-356
ページ数4
ジャーナルBrain Research
582
発行部数2
DOI
出版物ステータスPublished - 1992 6 12
外部発表Yes

Fingerprint

8-Hydroxy-2-(di-n-propylamino)tetralin
Suprachiasmatic Nucleus
Circadian Rhythm
Quipazine
Serotonin 5-HT1 Receptor Agonists
Neurons
Serotonin Receptor Agonists
Circadian Clocks
Raphe Nuclei
Running
Cricetinae
Serotonin
Brain
In Vitro Techniques
hydroxide ion

ASJC Scopus subject areas

  • Developmental Biology
  • Molecular Biology
  • Clinical Neurology
  • Neuroscience(all)

これを引用

Phase-resetting efect of 8-OH-DPAT, a serotonin1A receptor agonist, on the circadian rhythm of firing rate in the rat suprachiasmatic nuclei in vitro. / Shibata, Shigenobu; Tsuneyoshi, Atsuko; Hamada, Toshiyuki; Tominaga, Keiko; Watanabe, Shigenori.

:: Brain Research, 巻 582, 番号 2, 12.06.1992, p. 353-356.

研究成果: Article

Shibata, Shigenobu ; Tsuneyoshi, Atsuko ; Hamada, Toshiyuki ; Tominaga, Keiko ; Watanabe, Shigenori. / Phase-resetting efect of 8-OH-DPAT, a serotonin1A receptor agonist, on the circadian rhythm of firing rate in the rat suprachiasmatic nuclei in vitro. :: Brain Research. 1992 ; 巻 582, 番号 2. pp. 353-356.
@article{4213779c59904ea68ceec5078ad4417c,
title = "Phase-resetting efect of 8-OH-DPAT, a serotonin1A receptor agonist, on the circadian rhythm of firing rate in the rat suprachiasmatic nuclei in vitro",
abstract = "The 5-HTergic neurons in the mesencephalic raphe nuclei provide a robust projection to the hypothalamic suprachiasmatic nucleus (SCN), the site of a putative neuronal circadian pacemaker. Although it has been suggested that 5-HT neurons may play a role in the circadian timing system, this role has not yet been specified. Prosser et al. (Brain Res., 534 (1990) 336-339) reported that 1 h treatments with quipazine induce robust phase shifts in vitro, and that this effect depends upon the circadian time of treatment. However, quipazine is a non-specific 5-HT agonist. Besides, it is reported that the 5-HT1A agonist, 8-hydroxy-2-(di-n-propylamino)tetraline hydrobromide (8-OH-DPAT) affected a circadian rhythm of hamster wheel-running activity. In the present study we investigated whether the 5-HT1A agonist 8-OH-DPAT can reset the phase of the SCN clock when it is isolated in vitro. The present results show that 1 h treatments with 8-OH-DPAT induce robust phase advances in vitro when it was administered during the subjective day. This result suggests that 5HT1A receptor functioning may play a role in modulating the phase of SCN clock, especially during the subjective day.",
keywords = "5-Hydroxytryptamine, 8-OH-DPAT, Circadian rhythm, Serotonin 5-HT, Suprachiasmatic nucleus",
author = "Shigenobu Shibata and Atsuko Tsuneyoshi and Toshiyuki Hamada and Keiko Tominaga and Shigenori Watanabe",
year = "1992",
month = "6",
day = "12",
doi = "10.1016/0006-8993(92)90156-4",
language = "English",
volume = "582",
pages = "353--356",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Phase-resetting efect of 8-OH-DPAT, a serotonin1A receptor agonist, on the circadian rhythm of firing rate in the rat suprachiasmatic nuclei in vitro

AU - Shibata, Shigenobu

AU - Tsuneyoshi, Atsuko

AU - Hamada, Toshiyuki

AU - Tominaga, Keiko

AU - Watanabe, Shigenori

PY - 1992/6/12

Y1 - 1992/6/12

N2 - The 5-HTergic neurons in the mesencephalic raphe nuclei provide a robust projection to the hypothalamic suprachiasmatic nucleus (SCN), the site of a putative neuronal circadian pacemaker. Although it has been suggested that 5-HT neurons may play a role in the circadian timing system, this role has not yet been specified. Prosser et al. (Brain Res., 534 (1990) 336-339) reported that 1 h treatments with quipazine induce robust phase shifts in vitro, and that this effect depends upon the circadian time of treatment. However, quipazine is a non-specific 5-HT agonist. Besides, it is reported that the 5-HT1A agonist, 8-hydroxy-2-(di-n-propylamino)tetraline hydrobromide (8-OH-DPAT) affected a circadian rhythm of hamster wheel-running activity. In the present study we investigated whether the 5-HT1A agonist 8-OH-DPAT can reset the phase of the SCN clock when it is isolated in vitro. The present results show that 1 h treatments with 8-OH-DPAT induce robust phase advances in vitro when it was administered during the subjective day. This result suggests that 5HT1A receptor functioning may play a role in modulating the phase of SCN clock, especially during the subjective day.

AB - The 5-HTergic neurons in the mesencephalic raphe nuclei provide a robust projection to the hypothalamic suprachiasmatic nucleus (SCN), the site of a putative neuronal circadian pacemaker. Although it has been suggested that 5-HT neurons may play a role in the circadian timing system, this role has not yet been specified. Prosser et al. (Brain Res., 534 (1990) 336-339) reported that 1 h treatments with quipazine induce robust phase shifts in vitro, and that this effect depends upon the circadian time of treatment. However, quipazine is a non-specific 5-HT agonist. Besides, it is reported that the 5-HT1A agonist, 8-hydroxy-2-(di-n-propylamino)tetraline hydrobromide (8-OH-DPAT) affected a circadian rhythm of hamster wheel-running activity. In the present study we investigated whether the 5-HT1A agonist 8-OH-DPAT can reset the phase of the SCN clock when it is isolated in vitro. The present results show that 1 h treatments with 8-OH-DPAT induce robust phase advances in vitro when it was administered during the subjective day. This result suggests that 5HT1A receptor functioning may play a role in modulating the phase of SCN clock, especially during the subjective day.

KW - 5-Hydroxytryptamine

KW - 8-OH-DPAT

KW - Circadian rhythm

KW - Serotonin 5-HT

KW - Suprachiasmatic nucleus

UR - http://www.scopus.com/inward/record.url?scp=0026695257&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026695257&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(92)90156-4

DO - 10.1016/0006-8993(92)90156-4

M3 - Article

C2 - 1393558

AN - SCOPUS:0026695257

VL - 582

SP - 353

EP - 356

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 2

ER -